Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-23-014802
Filing Date
2023-03-30
Accepted
2023-03-30 16:01:00
Documents
4
Effectiveness Date
2023-03-30

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10050286_s8.htm S-8 74412
2 EXHIBIT 5.1 brhc10050286_ex5-1.htm EX-5.1 8225
3 EXHIBIT 23.2 brhc10050286_ex23-2.htm EX-23.2 2821
4 EXHIBIT 107 brhc10050286_ex107.htm EX-FILING FEES 11463
  Complete submission text file 0001140361-23-014802.txt   98065
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270981 | Film No.: 23780545
SIC: 2834 Pharmaceutical Preparations